- Company
- Aimmune Therapeutics, Inc.
- Ticker
- AIMT
Levi & Korsinsky announces it has commenced an investigation ofAimmune Therapeutics, Inc. (NASDAQ:AIMT) concerning possible breaches of fiduciary duty.
To receive more information, please fill out the form.